Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

George Eid

Surgery Pittsburgh, PA Medical Doctor

NPI 1992778393 CMS profile 135792

4815 Liberty Ave Ste 215, Pittsburgh, PA 15224

Open in the dashboard

General payments

$618,592

713 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$4,500 paid to institutions, not to them · program year 2024

Through program year 2025, George Eid of Pittsburgh, PA is reported in the CMS Open Payments database as having received $618,592 across 713 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $4,500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $156,941 171
2024 General $194,181 191
2023 General $88,087 113
2022 General $102,459 98
2021 General $46,689 67
2020 General $19,331 30
2019 General $10,903 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • George Eid
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to George Eid were reported at $156,941. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year George Eid Surgery median Middle half National median
2019 $10,903 $253 $82–$1,521 $163
2020 $19,331 $131 $40–$706 $114
2021 $46,689 $168 $50–$904 $132
2022 $102,459 $224 $76–$1,218 $149
2023 $88,087 $253 $82–$1,255 $160
2024 $194,181 $279 $90–$1,381 $164
2025 $156,941 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Novo Nordisk Inc $238,094 186 payments
  2. Lilly USA, LLC $143,522 119 payments
  3. Medtronic, Inc. $132,151 174 payments
  4. W. L. Gore & Associates, Inc. $31,898 67 payments
  5. Covidien LP $19,597 22 payments
  6. Ethicon US, LLC $18,249 12 payments
  7. Intuitive Surgical, Inc. $11,766 20 payments
  8. Transenterix, Inc. $8,407 21 payments
  9. Medical Device Business Services, Inc. $2,921 16 payments
  10. Novo Nordisk AS $2,748 3 payments
  11. Other $9,237 73 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $409,819 133 payments
  2. Consulting Fee $119,116 35 payments
  3. Travel and Lodging $46,341 135 payments
  4. Food and Beverage $28,149 404 payments
  5. Education $9,556 4 payments
  6. Honoraria $5,610 2 payments
Products named General payments · program years 2019–2025
  1. Wegovy $145,931 107 payments
  2. ZEPBOUND $137,841 106 payments
  3. Saxenda $92,055 82 payments
  4. Signia $25,347 75 payments
  5. GORE SEAMGUARD Bioabsorbable Staple Line Reinforce $14,747 24 payments
  6. Da Vinci Surgical System $11,766 20 payments
  7. GORE ENFORM Preperitoneal Biomaterial $11,273 11 payments
  8. GORE BIO-A Tissue Reinforcement $10,755 6 payments
  9. Echelon Flex $10,317 5 payments
  10. Senhance Manipulator Arm $8,407 21 payments
  11. Other $45,230 215 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 31 billing codes

Paid by Medicare

$37,745

Medicare's payments for the services billed

Medicare patients

60

Average age 64

Services billed

126

37 women, 23 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Depression 35%
Ischemic heart disease 32%
Diabetes 30%
Atrial fibrillation 22%
Chronic kidney disease 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ZEPBOUND
  • Lilly USA, LLC $55,323
$55,323 — —
Wegovy
  • Novo Nordisk Inc $55,149
$55,149 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

713 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record